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ABSTRACT :  A panel of six monoclonal antibodies against the nucleocapsid protein 
(NP) of Newcastle disease virus (NDV) strain AF2240 was produced by immunization of 
Balb/c mice with purified NP. Isotyping test revealed three of the monoclonal (mAbs) 
were IgG1 and the others were IgG2a. All of the mAbs recognized linearized NP 
epitopes. The reactivity of these mAbs with local isolates revealed that three mAbs 
recognized conserved antigenic sites and the others bind to antigenic sites which 
undergone considerable changes. 
Keywords: Monoclonal antibody; nucleocapsid; Newcastle disease virus. 
1. INTRODUCTION  
 Newcastle disease virus (NDV) is the only member of the new genus Avulavirus of 
the family Paramyxoviridae (Mayo, 2002). Initially, NDV was grouped in the 
Paramyxovirus genus. Later in 1993, it was placed within the genus Rubulavirus [1] 
together with simian virus 5, mumps virus, human parainfluenza virus type 2, type4a and 
4b. However, the lack of hydrophobic (SH) protein gene which is present in all other 
members of Rubulaviruses [2] causes it to be classified in the new genus.  
NDV infects many avian species and results in great economic lose in poultry 
industry. It can be divided into 3 pathotype groups based on the severity of the disease that 
the virus caused. Highly virulent NDV that causes viscerotropic and neurotropic 
symptoms are grouped as velogenic strains. Mesogenic strains caused milder respiratory 
diseases which are not usually fatal. The third group which is termed the lentogenic strain, 
causes inapparent respiratory disease [3].   
NDV contains a single-stranded non-segmented negative-sense genomic RNA of 
approximately 15.2 kb [4]. The genome encodes six major proteins namely the 
nucleocapsid protein (NP), the phosphoprotein (P), the large protein (L), the fusion 
glycoprotein (F), the heamaglutinin-neuraminidase glycoprotein (HN) and the matrix 
protein (M) [5]. The genome is encapsidated by the NP protein forming helical 
nucleocapsid and it protects the genome from nuclease activities. NP protein is the major 
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component of NDV. Each virion contains approximately 2600 NP [6]. Under electron 
microscope, it resembles a herringbone morphology which is in common with other 
members of Paramyxoviridae familiy. It plays a critical role in the replication of the virus 
in the host cells. Together with the viral genome, the complex acts as a template for 
genome synthesis and transcription during viral infection. 
NP was highly immunogenic in nature that it induces significant antibody 
responses in rabbits, mice and chickens however it fails to confer immunoprotection. 
Challenge of NP immunized chicken with virulent NDV strains result in mortalitys of the 
chicken within 5 days [7]. In contrast, rabies virus NP alone can induce protective 
immunity against lethal infection in mice and dogs [8, 9]. However, due to its 
immunogenic property, NP of NDV is used for diagnostic purposes in which NP-based 
immunoassays are used mainly to monitor vaccination programs and as a diagnostic test in 
differentiating between vaccinated and infected animals in conjunction with subunit 
vaccines [10]. MAbs against NP of NDV are not extensively studied except by a study 
carried out by Panshin and his collegues (2000) [23]. Most studies in many laboratories 
were focused on mAbs against HN and F proteins of NDV [11, 12, 13, 14, 15]as these 
glycoproteins have important roles in virulence and their antibodies conferred protective 
immunity to avian species [16, 17].  
 In this study, we described the production of a panel of mAbs against the NP and 
characterized the mAbs by isotyping, Western blotting and reactivity test towards different 
NDV strains. 
2. MATERIALS AND METHODS  
2.1 Viruses and cells 
 The NDV strains used in the cross-reactivity assay were lentogenic (4989/92 P3, 5270, 
5731/88 P4, 8820/92 P3); mesogenic (3147/89 P2) and velogenic (6270/92 P3). They were 
obtained from Veterinary Research Institute (VRI), Ipoh, Malaysia (Table 1). The viruses 
were propagated in embryonated chicken, harvested and semi-purified as described 
previously (Yusoff et al., 1996). The SP2/0-Ag14 myeloma cells (ATCC, USA) were used 
as fusion partners in the production of hybridoma cells. The cells were maintained in 
DMEM (Gibco, USA) with 10% fetal bovine serum, FBS (Gibco, USA) and were 
incubated at 37
o
C with 5% of CO2.  
2.2 Mouse immunization and mAbs production 
 Five to six weeks female Balb/C mice were immunized with 45 µg of purified NP full-
length protein for production of mAbs. A panel of mAbs against NP was prepared by 
fusing spleen cells from the immunized Balb/C mice with Sp2/0-Ag14 mouse myeloma 
cell line as described by [18]. The screening of the hybridoma producing antibodies was 
carried out by indirect ELISA using the purified NP as the antigen according to Hornbeck 
(1991) [19]. The cloning of the selected positive clones was perfomed by limiting dilution 
that was repeated three times to ensure monoclonality. 
2.3 Isotyping 
MAb isotyping was carried out on hybridoma culture supernatants using the Mouse 
Monoclonal Antibody Isotyping Kit (Pierce, USA). 
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2.4 SDS-PAGE and Western blot 
Purified NDV or NP proteins were separated by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) according to Laemmli (1970). After the 
electrophoresis, the fractionated proteins were blotted onto a nitrocellulose membrane 
(Osmonics, USA) and Western blotting was performed according to Harlow and Lane 
(1988) [20] with some modifications. The blotted membranes were incubated in culture 
fluids of mAbs instead of diluted serum before incubation with secondary antibody 
conjugated to alkaline phosphatase. Nitro-blue tetrazolium chloride (NBT; Amresco, 
USA) and bromochloroindolyl phosphate (BCIP; Amresco, USA) were used as a substrate 
solution. Polyclonal antiserum against NDV or NP was used as a positive control. 
2.5 Cross-reactivity assay 
Reactivity of the mAbs with different NDV isolates was tested by indirect ELISA with 
six local isolates collected from various outbreaks in Malaysia (Table 1). The indirect 
ELISA was conducted as described by Hornbeck (1991) except that 500 ng of semi-
purified virus which acts as antigen was adsorbed to the microtitre plates. Positive 
reactivity was considered when the mAbs supernatant produce an OD405 two fold higher 
than the control culture (SP2/0-Ag14). 
 
Table 1: Reactivities of mAbs with the local NDV isolates using indirect ELISA 
 
 MAbs against purified NP of NDV strain AF2240  
 
Viruses 
 
 
Yeara 
 
 
Pathotypeb 
a2 a2s b2 b4s c1 b3 
3147/89 P2 
 
1989 mesogenic +
c
 + + - + - 
4989/92 P3 
 
1992 lentogenic + + + - - - 
5270 
 
Not available lentogenic + + + + + - 
5731/88 P4 
 
1988 lentogenic + + + + + - 
6270/92 P3 
 
1992 velogenic + + + - - - 
8820/92 P3 
 
1992 lentogenic + + + + + - 
AF2240 
 
1974 velogenic + + + + + + 
a
 Year of isolation of the local NDV isolates 
b
 pathotype as determined by mean death time of embryonated eggs.  
c
+, Optical density at 405 nm (OD405) of the mAbs were two fold higher than the OD405  of 
a SP2/0-Ag14 culture supernatant in indirect ELISA; -, OD405 of the mAbs were less than 
twice the OD405 of a SP2/0-Ag14 culture supernatant in indirect ELISA. 
3. RESULTS AND DISCUSSION 
3.1 Production of mAbs against NP 
 
After the fusion, 91 wells from 468 seeded wells contained hybridomas producing NP-
specific antibodies. In order to optimize the selection, these hybridomas were then pooled 
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into two portions and cloned by 3 cycles of limiting dilution. Based on their high OD405 in 
indirect ELISA, five clones namely mAbs a2, a2s, b2, b3, b4s were obtained from one 
original portion and one clone, c1was from the other portion. MAb isotyping demonstrated 
that three of the mAbs (a2, a2s and b2) were IgG1 whilst the remaining mAbs (b4s, b3 and 
c1) were IgG2a (Table 2). All of the mAbs possess a kappa light chain but not lambda 
light chain.  
 
Table 2: Biological properties of mAbs against NP of NDV strain AF2240. 
 
Western Blot analysis 
 
MAbs 
 
Isotype Light chain 
NDV
a
 NP
b
 
a2 IgG1 kappa strong strong 
a2s IgG1 kappa strong strong 
b2 IgG1 kappa strong strong 
b4s IgG2a kappa medium medium 
c1 IgG2a kappa medium medium 
b3 IgG2a kappa medium medium 
 
a
 Western blot was carried out using purified NDV proteins blotted on nitrocellulose 
membrane 
b
 Western blot was carried out using purified NP blotted on nitrocellulose membrane 
 
3.2 Specificity of mAbs 
 
Western blotting was carried out to further determine the specificity of the mAbs. The 
results obtained revealed that all the mAbs bound to the purified NP proteins from E. coli 
(Figure 1a, lanes 3-8). These mAbs also bound specifically to NP (53 kDa) of the virus 
lysate and did not cross-react with other proteins of NDV (Figure 1b, lanes 3-8). However, 
one protein band with molecular mass smaller than the NP was also detected by the mAbs 
(Figure 2a, lanes 6-8; Figure 1b, lanes 4 and 5). The smaller fragment was full-length NP 
which had undergone proteolytic degradation. Similar observation on NP degradation was 
also observed by Hamaguchi et al. (1983) [21]. The biological properties of the mAbs 
were summarized in Table 2. 
The ability of all the mAbs to bind to the heat-denatured NP in the Western blot 
indicates that these antibodies recognize sequential or linear epitopes of the NP protein. 
None of the mAbs produced in the present study recognized conformational epitopes 
unlike two separate studies performed by Russell et al. (1983) [22] and Panshin et al. 
(2000) [23]who managed to obtain mAbs which recognized conformational epitopes in the 
NP protein. Perhaps during selection by limiting dilution, only those hybridoma clones 
which produced mAbs that bound to linear epitopes were selected.  
  
3.3 Reactivity of mAbs with different isolates 
 
The results demonstrate that mAbs a2, a2s and b2 reacted with all NDV isolates tested 
(Table 1). Hence, these mAb should recognize at least one highly conserved antigenic site 
of NP which present in all NDV isolates tested. Based on this result, indirectly it revealed 
that some antigenic sites of the NP protein from the local isolates remained conserved in 
spite of their pathogenicity and years they were isolated. The binding site for mAbs a2, a2s 
and b  appeared  to  be  highly  conserved  in  lentogenic,  mesogenic  and  velogenic NDV 
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(a)            1      2       3         4       5       6       7      8         9          M    kDa 
  
 
 
(b)             1     2    3         4         5        6      7      8          9         M      kDa 
   
 
Figure 1: Specificity of MAbs against NP. 
(a) Immunologic detection of NP after separation of purified NP by SDS-PAGE, 
electrophoretic transfer to nitrocellulose membrane (lane 9) and probed with mAbs b3, c1, 
b4s, b2, a2s and a2, (lane 3,4,5,6,7 and 8 respectively), polyclonal NP mouse serum 
(positive control, lane 1) and SP2/0-Ag14 culture supernatant (negative control, lane 2). 
The NP appeared as a sharp band of about 53 kDa when probed with various mAbs 
against NP and polyclonal against NP mouse serum. No band was detected when probed 
with SP2/0-Ag14 culture supernatant. 
(b) Purified NDV (lane 9) was probed with mAbs a2s, b2, a2, b3, c1 and b4s (lane 
3,4,5,6,7 and 8 respectively), polyclonal NP mouse serum (positive control, lane 1) and 
SP2/0-Ag14 culture supernatant (negative control, lane 2). NP, nucleocapsid protein; F/P, 
fusion/ phosphoprotein; HN, hemagglutinin-neuraminidase, M, protein molecular weight. 
 
strains and they were probably similar to that site recognized by mAbs 38 generated by 
Russell et al. (1983) [22] and mAbs 401 and 402 produced by Nishikawa et al. (1987)  
[24] since these antibodies cross-reacted extensively with all NDV strains tested. On the 
other hand, although mAbs 479 (Russell et al., 1983) [22], 18d2 and 12f8 (Panshin et al., 
2000) [23] exhibited full reactivity with all NDV strains tested, the conserved antigenic 
sites bound by these antibodies differs from the present study because they recognized 
conformational epitopes only. 
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On the other hand, mAb b3 did not react with any of the isolates except for the strain 
AF2240 which was used to immunize the mice for the fusion step. MAbs b3 obtained 
from this study appeared to be specific for the isolate (AF2240) used to prepare the 
antibody. Although this antibody has the potential to be used as a diagnostic reagent in 
detecting NDV strain AF2240, further tests with a larger panel of NDV isolates will be 
needed in order to validate the ultimate specificity. Previous study has shown that mAbs 3 
and 43 (mAbs against NP of NDV) that reacted specifically against NDV strain 617/83 
from 18 other NDV isolates in one study reacted with other isolates when further tested 
with a larger panel of NDV isolates of 818 in another study [25, 26]. 
The other two mAbs (b4s and c1) bound to NDV isolates with varying reactivities. For 
example, mAb b4s reacted with three of the six isolates (isolates 5270, 5731/88/P4 and 
8820/92/P3) and mAb c1 bound an additional, mesogenic isolate, 3147/89/P2. These 
antibodies seem to be not specific to viral virulence as they react to both lentogenic as well 
as velogenic isolates. In addition, mAb c1 also reacted with the mesogen. Probably, the 
regions recognized by both of the antibodies could have undergone some structural 
changes or the epitopes bound by them are not conserved amino acid sequences and it 
varies in different isolates. 
4. CONCLUSIONS  
In the present study, a panel of six monoclonal antibodies against the NP of a heat-
resistant virulent NDV strain AF2240 was produced by immunization of Balb/c mice with 
purified NP protein. All of the mAbs showed specificity against NP protein only and did 
not cross-react with other proteins of NDV. The ability of all the mAbs to bind to the heat-
denatured NP in the Western blot indicates that these antibodies recognize sequential or 
linear epitopes of the NP protein. The reactivity test revealed that some of the antigenic 
sites of the NP protein from the local isolates remained conserved in spite of their 
pathogenicity and years they were isolated. While, some other sites were subjected to 
moderate and remarkable changes. 
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